Elizabeth G. O'Farrell's Net Worth
$292 Thousand
Who is Elizabeth G. O'Farrell?
Elizabeth G. O'Farrell does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include GERON CORP, LENSAR, Inc., Inhibikase Therapeutics, Inc., and PDL BIOPHARMA, INC..
SEC CIK
Elizabeth G. O'Farrell's CIK is 0001744662
Past Insider Trading and Trends
2020 was Elizabeth G. O'Farrell's most active year for acquiring shares with 5 total transactions. Elizabeth G. O'Farrell's most active month to acquire stocks was the month of April. 2020 was Elizabeth G. O'Farrell's most active year for disposing of shares, totalling 2 transactions. Elizabeth G. O'Farrell's most active month to dispose stocks was the month of October. 2020 saw Elizabeth G. O'Farrell paying a total of $431,855.73 for 235,122 shares, this is the most they've acquired in one year. In 2020 Elizabeth G. O'Farrell cashed out on 89,117 shares for a total of $213,711.31, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
GERON CORP (GERN) Snapshot price: $4.29
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 9
| |||
Form 4
| +64.51% | 13.19K |
$2.28 | $30,064.08 | 33.63K |
Aug 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 11
| |||
Form 4
| +792.77% | 17.44K |
$1.73 | $30,172.93 | 19.64K |
Aug 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
∞
| 3K |
$1.35 | $4,028.00 | 3K |
Jan 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
LENSAR, Inc. (LNSR) Snapshot price: $4.9867
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +106.94% | 22K |
—
|
—
| 42.57K |
May 7
| |||
Form 4
| +82.30% | 9.29K |
—
|
—
| 20.57K |
May 25
| |||
Form 4
| +61.21% | 4.29K |
—
|
—
| 11.29K |
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Inhibikase Therapeutics, Inc. (IKT) Snapshot price: $1.35
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PDL BIOPHARMA, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -25.83K |
$2.44 | -$63,015.44 |
0
|
Nov 23
| |||
Form 4
| -71.02% | -63.29K |
$2.38 | -$150,695.87 | 25.83K |
Nov 18
| |||
Form 4
| +40.81% | 25.83K |
—
|
—
| 89.12K |
Aug 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
∞
| 63.29K |
$2.37 | $149,999.67 | 63.29K |
Jun 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||